New Treatment Options on the Horizon for Chronic Spontaneous Urticaria

(MedPage Today) -- LOUISVILLE, Ky. -- Treatment with add-on dupilumab (Dupixent) was linked with clinically meaningful improvements in hives and itch severity in patients with chronic spontaneous urticaria (CSU), according to the LIBERTY-CSU...
Source: MedPage Today Allergy - Category: Allergy & Immunology Source Type: news